The Issuance Machine Roars Back: A $29 Billion ADR, Tiered Lockups, and the Summer Supply Test

The second half of 2026 opens with the equity-issuance machine running at a pace the market has not absorbed in years. SK hynix is set to price what could be the largest American depositary share offering in history on July 10, targeting up to $29.4 billion on Nasdaq under the ticker SKHY. SpaceX, which raised a record sum in its own IPO three weeks ago, begins a tiered lockup release as early as late July. A cluster of secondaries, follow-ons, and the first simultaneous NYSE-plus-onchain listing all landed in the first trading days of July. And underneath it all, a $350 billion liquidity drain and a structural transformation in equity-market plumbing set the backdrop for how much supply the system can actually absorb.

This is not a normal July. The question is whether the market’s plumbing — which Citadel Securities argues has fundamentally changed — can handle it.

The Headliner: SK hynix’s $29.4 Billion ADR

South Korea’s SK hynix, the world’s second-largest memory chipmaker, filed an amended registration with the SEC on June 30 and is targeting a Nasdaq debut on July 10 under the symbol SKHY. The company plans to issue up to 17.79 million American depositary shares, each representing a fraction of a common share already listed on the KOSPI under 000660. At the top of the indicated range, the offering would raise approximately 45.45 trillion won, or roughly $29.4 billion — surpassing Alibaba’s $21.8 billion 2014 New York listing as the largest ADR offering on record.

The deal is underwritten by BofA and Citi, and the proceeds are earmarked for Korean fabrication capacity and EUV lithography equipment — the capital-intensive infrastructure behind high-bandwidth memory (HBM) that feeds the AI accelerator supply chain. SK hynix has been one of the hottest stocks on the KOSPI in 2026, and the listing arrives as the company seeks to broaden its investor base beyond Korea’s domestic market.

But the timing carries a tension. The AI chip trade that underpins SK hynix’s valuation has shown signs of wobbling in recent weeks, with Nvidia and related names pulling back from their highs. A $29 billion ADR priced into a softening AI sentiment cycle is a test of whether global capital will absorb the supply at the indicated range — or whether the bookrunners will need to narrow it.

SpaceX’s Tiered Lockup: A Rolling Supply Shock

SpaceX’s IPO three weeks ago set the record for the largest initial public offering in history. Now the harder structural question is emerging: when do the locked shares start trading?

Unlike a standard 180-day lockup, SpaceX’s S-1 established a tiered, rolling release schedule designed to meter — not block — sales by pre-IPO shareholders. According to the 424(b)(4) prospectus and subsequent analysis, only approximately 5% of SpaceX’s shares are freely trading right now. The remaining 95% unlocks in tranches over the next 12 months.

The first selling window opens after SpaceX reports Q2 2026 earnings, expected in late July or early August. A broader 180-day lockup expires December 8, 2026. Elon Musk’s approximately 6.4 billion shares — representing roughly 42% of the company and 82% of voting power through Class B stock — are locked until June 12, 2027.

The tiered structure is designed to prevent a single-date supply cliff, but it also means the float expands in waves rather than all at once. Analysts at 22V Research have flagged the lockup schedule as a source of persistent overhang, and Trefis noted in late June that even after a 30% three-day selloff, the stock still traded at roughly 100x trailing revenue — a level that leaves limited cushion if early unlock tranches meet weak demand.

Former SEC chair Gary Gensler publicly described the upcoming August unlock as potentially triggering a “great rebalancing” as early backers take profits — a characterization that, whatever its accuracy, signals how closely the market is watching the timeline.

The Secondary and Follow-On Wave

The first trading week of July produced a burst of follow-on and secondary offerings that, taken together, represent a meaningful test of risk appetite:

The Abivax deal is the standout. An oversubscribed, upsized biotech follow-on that priced at a premium to VWAP and saw full greenshoe exercise is a strong demand signal — particularly in a sector (clinical-stage inflammation therapeutics) where follow-on execution is far from guaranteed. The fact that underwriters exercised their full option to bring gross proceeds from $800 million to $920 million suggests institutional appetite for growth-equity supply remains intact, at least for quality names.

Sable Offshore’s concurrent equity-and-convertible package is a different animal — a balance-sheet reset funded by dilutive equity at $3.08 per share alongside $300 million in convertible debt. The structure signals a company leaning on capital markets rather than operating cash flow to manage its obligations, and the pricing will tell whether energy-sector investors are receptive to that trade.

BrightSpring’s secondary is the cleanest example of the sponsor-exit dynamic: KKR and management sold 15 million existing shares, with the company buying back roughly 1 million in a concurrent repurchase to partially offset the supply. The transaction did not raise new capital for BrightSpring — it was a liquidity event for existing holders, and the buyback was a signal-management gesture rather than a meaningful offset.

Securitize: The First Tokenized Stock Listing

On July 2, Securitize Corp. began trading on the NYSE under the ticker SECZ, becoming the first company to simultaneously list common stock on a traditional exchange and issue issuer-sponsored tokenized shares on blockchain networks. The tokenized shares — $295 million of the company’s common stock — were made available to eligible U.S. investors on both Solana and Avalanche on listing day.

The debut came via a business combination with Cantor Equity Partners II, a blank-check company backed by Cantor Fitzgerald. Securitize, which has brought over $4 billion in assets onchain as a tokenization platform, used its own listing as a proof-of-concept for the dual-market structure that regulators formally enabled roughly six months earlier.

This is a market-structure development worth tracking separately from the deal’s own economics. If issuer-sponsored tokenized equities gain traction, the traditional settlement and clearing pipeline faces a parallel rails question: does T+1 settlement coexist with near-instant onchain transfer, and what does that mean for liquidity, short-selling, and corporate-actions processing? The SEC’s options market structure roundtable in April 2026 and the New York Fed’s workshop on market liquidity and functioning on July 9 both touch adjacent territory.

The Liquidity Backdrop: A $350 Billion Drain

All of this issuance lands against a liquidity picture that is tightening. A widely circulated analysis projects a $350 billion liquidity drain hitting markets over the summer, driven by Treasury issuance, QT runoff, and the seasonal contraction in bank reserves that typically accompanies quarter-end through mid-July.

Citadel Securities’ Scott Rubner, in his June 30 “1H 2026 Market Structure & Flows” report, framed the defining story of 2026 not as any single macro event but as the structural transformation of equity markets — pointing to record retail participation, massive options expirations, and concentration dynamics that have made index-level calm mask significant intra-market volatility. His May 18 “Flow Fragility” note flagged the market as vulnerable to a potential flow-of-funds unwind even while remaining medium-term bullish, citing the S&P 500’s roughly $10 trillion market-cap addition from the March 30 low.

The intersection of a $29 billion ADR, rolling SpaceX lockup unlocks, a wave of secondaries, and a $350 billion liquidity drain is the kind of confluence that market-structure analysts flag not because any single component is unprecedented, but because the combination tests the system’s capacity to intermediate supply under tightening conditions.

What to Watch Next

• SK hynix pricing (July 10): Whether the deal prices within the indicated range or needs to be narrowed will be the single most important demand signal for large-cap ADR supply. A clean print at $29 billion tells you global capital is absorbing AI-adjacent issuance at scale; a discount tells you the AI sentiment wobble has real teeth.

• SpaceX Q2 earnings and first unlock tranche (late July / early August): The tiered lockup’s first selling window opens after earnings. Watch the volume and price action in the days surrounding the unlock — not the headline number, but whether the float expansion is absorbed or produces a sustained discount.

• New York Fed liquidity workshop (July 9): Academics, industry experts, and central bankers convene to discuss innovations in payments, trading, and market functioning. Any signal on settlement reform or Treasury market structure has implications for the plumbing that all this issuance runs through.

• Secondary and follow-on calendar pacing: If the Abivax-style oversubscribed premium pricing continues across subsequent deals, the follow-on market is open and functioning. If deals start pricing at discounts or getting pulled, that is the first sign the supply-demand balance is turning.

• Securitize tokenized-equity adoption: Whether any subsequent issuer follows SECZ’s dual-listing model will determine whether tokenized equities are a novelty or the beginning of a parallel settlement rail. Watch for additional S-1 filings that reference onchain issuance.

The base case is that the market absorbs this supply — the demand signals from Abivax and the retail participation trends Rubner highlights are genuinely strong. But the 40% scenario — where SK hynix prices at a discount, the first SpaceX unlock tranche triggers a step-down, and the liquidity drain amplifies both — is not a tail risk. It is a real path, and the next two weeks of pricing data will tell you which one you are on.